Soren Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 27, 2026
MWN-AI** Summary
Soren Acquisition Corp. (Nasdaq: SORNU) announced that beginning February 27, 2026, holders of the Units from its initial public offering can separately trade their Class A ordinary shares and redeemable warrants. Each Unit consists of one Class A ordinary share and one-third of a Warrant, with whole Warrants allowing the purchase of one Class A ordinary share at $11.50. The Class A ordinary shares and Warrants will be traded on the Nasdaq Global Market under the tickers “SORN” and “SORNW,” respectively, while units that are not separated will continue trading under “SORNU.”
The offering was managed by BTIG, LLC, and the announcement emphasizes that this should not be interpreted as a solicitation for investment in the Company’s securities unless properly registered according to applicable laws.
Soren Acquisition Corp. is a blank check company aiming to execute mergers and business combinations, focusing particularly on the healthcare sector. Under the leadership of CEO Arghavan Di Rezze and CFO Jamie Weber, the Company’s Board also comprises Marc Mazur, Charles N. Khan III, and Spencer Gerrol, with Peter Ondishin and Nicholas Shekerdemian serving as advisors.
The release contains forward-looking statements regarding future business combinations and related financial matters, which are based on the management's beliefs and assumptions. These statements point to potential outcomes but caution that actual results could vary due to numerous factors, especially as laid out in the Company’s filings with the SEC. The Company disclaims any obligation to update forward-looking statements beyond legal requirements. For inquiries, contact Arghavan Di Rezze at the provided email.
MWN-AI** Analysis
As Soren Acquisition Corp. (Nasdaq: SORNU) prepares to commence separate trading of its Class A Ordinary Shares and Warrants on February 27, 2026, investors should be mindful of both the potential opportunities and risks associated with this development. The separation of Units, which consist of one Class A Ordinary Share and one-third of a Warrant, allows flexibility for investors. Each whole Warrant can be exercised to purchase an additional share at $11.50, presenting a potentially attractive marginal investment for those optimistic about the company’s future valuation.
Soren Acquisition Corp. is positioned as a blank check company, with a specific focus on merging with businesses in the healthcare sector. Given the ongoing transformations in healthcare technology and delivery, opportunities for growth in this area remain robust. Investors should assess the company's ability to identify and pursue lucrative acquisition targets that can thrive in today’s evolving healthcare landscape.
It’s also essential to consider the overall market environment and the company’s current trading conditions. As of now, investors can trade the Units under the symbol "SORNU", which may retain additional appeal until the separate shares and Warrants trading begins. Daily trading volume and market sentiment leading up to the separation could significantly impact pricing dynamics, and investors should monitor these factors closely.
However, it's vital to remain cautious. As highlighted in their forward-looking statements, potential investors should be aware that actual outcomes can diverge significantly from projections due to various factors. Regulatory risks, market volatility, and execution risks regarding future business combinations could influence performance.
In summary, while the separation of shares and Warrants presents an intriguing opportunity, investors should conduct thorough due diligence, keeping a close eye on market trends and the execution of Soren Acquisition's strategic initiatives before making definitive investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Soren Acquisition Corp. (Nasdaq: SORNU) (the “Company”) announced today that, commencing February 27, 2026, the holders of the units issued in the Company’s initial public offering (the “Units”), each consisting of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-third of one redeemable warrant of the Company (each, a “Warrant”), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, may elect to separately trade the Class A Ordinary Shares and the Warrants included in the Units. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Class A Ordinary Shares and the Warrants will trade on the Nasdaq Global Market under the symbols “SORN” and “SORNW,” respectively. Units not separated will continue to trade on the Nasdaq Global Market under the symbol “SORNU.”
BTIG, LLC acted as sole book-running manager for the offering.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Soren Acquisition Corp.
The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution but is focused on completing a business combination with an attractive target business within the healthcare industry.
The Company’s management team is led by Arghavan Di Rezze, its Chief Executive Officer, and Jamie Weber, its Chief Financial Officer, who are both members of the Board of Directors of the Company (the “Board”). In addition, the Board includes Marc Mazur, Charles N. Khan III and Spencer Gerrol. Peter Ondishin and Nicholas Shekerdemian serve as advisors to the Company.
FORWARD-LOOKING STATEMENTS
This press release may include, and oral statements made from time to time by representatives of the Company may include, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission (“SEC”). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Company Contact
Soren Acquisition Corp.
Arghavan Di Rezze, Chief Executive Officer
apd@direzzefamilyoffice.com
FAQ**
How does the separation of the Soren Acquisition Corp. Unit SORNU into Class A Ordinary Shares and Warrants impact trading liquidity for investors starting February 27, 2026?
What specific acquisition opportunities within the healthcare industry does Soren Acquisition Corp. envision pursuing following the separation of the Unit SORNU?
Given the focus on healthcare, what criteria will Soren Acquisition Corp. use to evaluate potential business combinations after the separation of Unit SORNU?
In light of forward-looking statements, what are the main risks associated with investing in Soren Acquisition Corp. Unit SORNU and how might they affect the company's future performance?
**MWN-AI FAQ is based on asking OpenAI questions about Soren Acquisition Corp. Unit (NASDAQ: SORNU).
NASDAQ: SORNU
SORNU Trading
0.2% G/L:
$9.95 Last:
710 Volume:
$9.92 Open:
